Clinical pharmacology of tobramycin in newborns.
D000606:Amino Sugars / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use / Q000652:urine; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D001724:Birth Weight; D002986:Clinical Trials as Topic; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006027:Glycosides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D007231:Infant, Newborn; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011513:Proteus mirabilis / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D003470:Culture Media; D006027:Glycosides